{"entity":{"type":"insider","cik":"0001274826","url":"/insider/0001274826","json_url":"/insider/0001274826.json","name":"BAFFI ROBERT","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":479,"n_filings":49,"first":"2004-05-11","last":"2018-08-09","span_basis":"filed_date"},"name_variants":[{"name":"BAFFI ROBERT","source":"filing","n_filings":49,"first_seen":"2004-05-11","last_seen":"2018-08-09"}],"transactions":[{"id":6102798,"accession":"0001567619-18-000257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-000257","line_url":"/filing/0001567619-18-000257#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5173.0,"shares_display":"5,173","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":543165.0,"total_display":"543,165.00","total_whole":"543,165","shares_owned_after":71882.0,"shares_owned_after_display":"71,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-09","scope":"insider"},{"id":6310959,"accession":"0001140361-18-030008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-030008","line_url":"/filing/0001140361-18-030008","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6949.0,"shares_display":"6,949","price_per_share":99.00047201036121,"price_display":"99.00","price_state":"stated","total_value":687954.28,"total_display":"687,954.28","total_whole":"687,954","shares_owned_after":83604.0,"shares_owned_after_display":"83,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-26","scope":"insider","n_lines":2},{"id":4702470,"accession":"0001140361-17-037214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-037214","line_url":"/filing/0001140361-17-037214","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18415.0,"shares_display":"18,415","price_per_share":92.4263100733098,"price_display":"92.43","price_state":"stated","total_value":1702030.5,"total_display":"1,702,030.50","total_whole":"1,702,031","shares_owned_after":129083.0,"shares_owned_after_display":"129,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-28","filed_date":"2017-10-02","scope":"insider","n_lines":2},{"id":2887760,"accession":"0001140361-16-066270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-066270","line_url":"/filing/0001140361-16-066270#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":87.0497,"price_display":"87.05","price_state":"stated","total_value":435248.5,"total_display":"435,248.50","total_whole":"435,249","shares_owned_after":130386.0,"shares_owned_after_display":"130,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":8646065,"accession":"0001140361-15-010596","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-010596","line_url":"/filing/0001140361-15-010596#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14051.0,"shares_display":"14,051","price_per_share":116.3683,"price_display":"116.37","price_state":"stated","total_value":1635090.9833,"total_display":"1,635,090.98","total_whole":"1,635,091","shares_owned_after":109700.0,"shares_owned_after_display":"109,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider"},{"id":6805254,"accession":"0001140361-14-039696","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001140361-14-039696","line_url":"/filing/0001140361-14-039696#line-7","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29963.0,"shares_display":"29,963","price_per_share":81.6994,"price_display":"81.70","price_state":"stated","total_value":2447959.1222,"total_display":"2,447,959.12","total_whole":"2,447,959","shares_owned_after":99200.0,"shares_owned_after_display":"99,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-31","scope":"insider"},{"id":6805240,"accession":"0001140361-14-039696","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-14-039696","line_url":"/filing/0001140361-14-039696#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45462.0,"shares_display":"45,462","price_per_share":81.0997,"price_display":"81.10","price_state":"stated","total_value":3686954.5614,"total_display":"3,686,954.56","total_whole":"3,686,955","shares_owned_after":99200.0,"shares_owned_after_display":"99,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-31","scope":"insider"},{"id":4684280,"accession":"0001140361-13-035602","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-035602","line_url":"/filing/0001140361-13-035602#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":1460000.0,"total_display":"1,460,000.00","total_whole":"1,460,000","shares_owned_after":62262.0,"shares_owned_after_display":"62,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-09","filed_date":"2013-09-11","scope":"insider"},{"id":5419928,"accession":"0001140361-13-020897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-020897","line_url":"/filing/0001140361-13-020897#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":1400000.0,"total_display":"1,400,000.00","total_whole":"1,400,000","shares_owned_after":50262.0,"shares_owned_after_display":"50,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider"},{"id":5483811,"accession":"0001140361-13-019271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-019271","line_url":"/filing/0001140361-13-019271#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":1340000.0,"total_display":"1,340,000.00","total_whole":"1,340,000","shares_owned_after":53155.0,"shares_owned_after_display":"53,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-03","filed_date":"2013-05-07","scope":"insider"},{"id":4440454,"accession":"0001140361-13-016375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-016375","line_url":"/filing/0001140361-13-016375#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":1280000.0,"total_display":"1,280,000.00","total_whole":"1,280,000","shares_owned_after":52350.0,"shares_owned_after_display":"52,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-04-12","scope":"insider"},{"id":4418501,"accession":"0001140361-13-013358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-013358","line_url":"/filing/0001140361-13-013358#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":61.018,"price_display":"61.02","price_state":"stated","total_value":1220360.0,"total_display":"1,220,360.00","total_whole":"1,220,360","shares_owned_after":52350.0,"shares_owned_after_display":"52,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-20","scope":"insider"},{"id":4965553,"accession":"0001140361-13-002908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-002908","line_url":"/filing/0001140361-13-002908#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19575.0,"shares_display":"19,575","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":1076625.0,"total_display":"1,076,625.00","total_whole":"1,076,625","shares_owned_after":100413.0,"shares_owned_after_display":"100,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-23","scope":"insider"},{"id":5483086,"accession":"0001140361-13-001343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-001343","line_url":"/filing/0001140361-13-001343#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":53.0,"price_display":"53.00","price_state":"stated","total_value":1060000.0,"total_display":"1,060,000.00","total_whole":"1,060,000","shares_owned_after":100413.0,"shares_owned_after_display":"100,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-07","scope":"insider"},{"id":3011799,"accession":"0001140361-12-048025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-048025","line_url":"/filing/0001140361-12-048025#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.0,"price_display":"51.00","price_state":"stated","total_value":1020000.0,"total_display":"1,020,000.00","total_whole":"1,020,000","shares_owned_after":100413.0,"shares_owned_after_display":"100,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-15","filed_date":"2012-11-19","scope":"insider"},{"id":3472728,"accession":"0001140361-12-046055","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-12-046055","line_url":"/filing/0001140361-12-046055","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":47.333333333333336,"price_display":"47.33","price_state":"stated","total_value":2840000.0,"total_display":"2,840,000.00","total_whole":"2,840,000","shares_owned_after":100413.0,"shares_owned_after_display":"100,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-05","filed_date":"2012-11-07","scope":"insider","n_lines":4},{"id":4724347,"accession":"0001140361-13-007711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-007711","line_url":"/filing/0001140361-13-007711#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161.0,"shares_display":"161","price_per_share":21.76,"price_display":"21.76","price_state":"stated","total_value":3503.36,"total_display":"3,503.36","total_whole":"3,503","shares_owned_after":100574.0,"shares_owned_after_display":"100,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-31","filed_date":"2013-02-15","scope":"insider"},{"id":2203063,"accession":"0001140361-12-044092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-044092","line_url":"/filing/0001140361-12-044092#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":43.0,"price_display":"43.00","price_state":"stated","total_value":860000.0,"total_display":"860,000.00","total_whole":"860,000","shares_owned_after":100413.0,"shares_owned_after_display":"100,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-18","scope":"insider"},{"id":3529030,"accession":"0001140361-12-011413","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-12-011413","line_url":"/filing/0001140361-12-011413#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91313.0,"shares_display":"91,313","price_per_share":34.8361,"price_display":"34.84","price_state":"stated","total_value":3180988.7993,"total_display":"3,180,988.80","total_whole":"3,180,989","shares_owned_after":83493.0,"shares_owned_after_display":"83,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-28","scope":"insider"},{"id":2488585,"accession":"0001140361-12-008364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-008364","line_url":"/filing/0001140361-12-008364#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333.0,"shares_display":"333","price_per_share":13.26,"price_display":"13.26","price_state":"stated","total_value":4415.58,"total_display":"4,415.58","total_whole":"4,416","shares_owned_after":83493.0,"shares_owned_after_display":"83,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-31","filed_date":"2012-02-14","scope":"insider"},{"id":9129889,"accession":"0001140361-11-039629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-039629","line_url":"/filing/0001140361-11-039629#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18687.0,"shares_display":"18,687","price_per_share":30.55,"price_display":"30.55","price_state":"stated","total_value":570887.85,"total_display":"570,887.85","total_whole":"570,888","shares_owned_after":83160.0,"shares_owned_after_display":"83,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-02","filed_date":"2011-08-04","scope":"insider"},{"id":9231472,"accession":"0001140361-10-044042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-044042","line_url":"/filing/0001140361-10-044042#line-1","is_derivative":false,"issuer_cik":"0001274826","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001274826","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.244,"price_display":"25.24","price_state":"stated","total_value":50488.0,"total_display":"50,488.00","total_whole":"50,488","shares_owned_after":67713.0,"shares_owned_after_display":"67,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-03","filed_date":"2010-11-05","scope":"insider"},{"id":7199771,"accession":"0001140361-10-043899","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-043899","line_url":"/filing/0001140361-10-043899#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.244,"price_display":"25.24","price_state":"stated","total_value":50488.0,"total_display":"50,488.00","total_whole":"50,488","shares_owned_after":67713.0,"shares_owned_after_display":"67,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-03","filed_date":"2010-11-05","scope":"insider"},{"id":5252184,"accession":"0001140361-13-013356","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-013356","line_url":"/filing/0001140361-13-013356#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163888.0,"shares_display":"163,888","price_per_share":22.5216,"price_display":"22.52","price_state":"stated","total_value":3691019.9808,"total_display":"3,691,019.98","total_whole":"3,691,020","shares_owned_after":60588.0,"shares_owned_after_display":"60,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-10","filed_date":"2013-03-20","scope":"insider"},{"id":5679201,"accession":"0001048477-09-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-09-000012","line_url":"/filing/0001048477-09-000012#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technial Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":229.0,"shares_display":"229","price_per_share":13.354,"price_display":"13.35","price_state":"stated","total_value":3058.066,"total_display":"3,058.07","total_whole":"3,058","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-31","filed_date":"2009-02-12","scope":"insider"},{"id":2558834,"accession":"0001048477-08-000213","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001048477-08-000213","line_url":"/filing/0001048477-08-000213#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11528.0,"shares_display":"11,528","price_per_share":31.312,"price_display":"31.31","price_state":"stated","total_value":360964.736,"total_display":"360,964.74","total_whole":"360,965","shares_owned_after":38434.0,"shares_owned_after_display":"38,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-04","scope":"insider"},{"id":4009750,"accession":"0001048477-08-000196","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-30","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":31.9,"price_display":"31.90","price_state":"stated","total_value":98890.0,"total_display":"98,890.00","total_whole":"98,890","shares_owned_after":48984.0,"shares_owned_after_display":"48,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009748,"accession":"0001048477-08-000196","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-29","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.78,"price_display":"31.78","price_state":"stated","total_value":19068.0,"total_display":"19,068.00","total_whole":"19,068","shares_owned_after":53634.0,"shares_owned_after_display":"53,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009746,"accession":"0001048477-08-000196","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-28","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.511,"price_display":"31.51","price_state":"stated","total_value":18906.6,"total_display":"18,906.60","total_whole":"18,907","shares_owned_after":55268.0,"shares_owned_after_display":"55,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009743,"accession":"0001048477-08-000196","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-27","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550.0,"shares_display":"550","price_per_share":31.82,"price_display":"31.82","price_state":"stated","total_value":17501.0,"total_display":"17,501.00","total_whole":"17,501","shares_owned_after":52684.0,"shares_owned_after_display":"52,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009740,"accession":"0001048477-08-000196","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-26","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":31.24,"price_display":"31.24","price_state":"stated","total_value":15620.0,"total_display":"15,620.00","total_whole":"15,620","shares_owned_after":57034.0,"shares_owned_after_display":"57,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009738,"accession":"0001048477-08-000196","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-25","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.79,"price_display":"31.79","price_state":"stated","total_value":12716.0,"total_display":"12,716.00","total_whole":"12,716","shares_owned_after":53234.0,"shares_owned_after_display":"53,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009736,"accession":"0001048477-08-000196","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-24","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.57,"price_display":"31.57","price_state":"stated","total_value":9471.0,"total_display":"9,471.00","total_whole":"9,471","shares_owned_after":54868.0,"shares_owned_after_display":"54,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009734,"accession":"0001048477-08-000196","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-23","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":31.91,"price_display":"31.91","price_state":"stated","total_value":7977.5,"total_display":"7,977.50","total_whole":"7,978","shares_owned_after":48734.0,"shares_owned_after_display":"48,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009732,"accession":"0001048477-08-000196","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-22","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":234.0,"shares_display":"234","price_per_share":31.63,"price_display":"31.63","price_state":"stated","total_value":7401.42,"total_display":"7,401.42","total_whole":"7,401","shares_owned_after":54634.0,"shares_owned_after_display":"54,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009730,"accession":"0001048477-08-000196","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-21","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":6378.0,"total_display":"6,378.00","total_whole":"6,378","shares_owned_after":52084.0,"shares_owned_after_display":"52,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009728,"accession":"0001048477-08-000196","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-20","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.85,"price_display":"31.85","price_state":"stated","total_value":6370.0,"total_display":"6,370.00","total_whole":"6,370","shares_owned_after":52284.0,"shares_owned_after_display":"52,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009726,"accession":"0001048477-08-000196","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-19","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.841,"price_display":"31.84","price_state":"stated","total_value":6368.2,"total_display":"6,368.20","total_whole":"6,368","shares_owned_after":52484.0,"shares_owned_after_display":"52,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009724,"accession":"0001048477-08-000196","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-18","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.68,"price_display":"31.68","price_state":"stated","total_value":6336.0,"total_display":"6,336.00","total_whole":"6,336","shares_owned_after":54334.0,"shares_owned_after_display":"54,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009723,"accession":"0001048477-08-000196","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-17","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.51,"price_display":"31.51","price_state":"stated","total_value":6302.0,"total_display":"6,302.00","total_whole":"6,302","shares_owned_after":55868.0,"shares_owned_after_display":"55,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009722,"accession":"0001048477-08-000196","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-16","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.47,"price_display":"31.47","price_state":"stated","total_value":6294.0,"total_display":"6,294.00","total_whole":"6,294","shares_owned_after":56168.0,"shares_owned_after_display":"56,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009719,"accession":"0001048477-08-000196","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-15","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.35,"price_display":"31.35","price_state":"stated","total_value":6270.0,"total_display":"6,270.00","total_whole":"6,270","shares_owned_after":56634.0,"shares_owned_after_display":"56,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009718,"accession":"0001048477-08-000196","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-14","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.15,"price_display":"31.15","price_state":"stated","total_value":6230.0,"total_display":"6,230.00","total_whole":"6,230","shares_owned_after":57534.0,"shares_owned_after_display":"57,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009716,"accession":"0001048477-08-000196","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-13","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":3169.0,"total_display":"3,169.00","total_whole":"3,169","shares_owned_after":54234.0,"shares_owned_after_display":"54,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"},{"id":4009714,"accession":"0001048477-08-000196","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001048477-08-000196","line_url":"/filing/0001048477-08-000196#line-12","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001274826","owner_name":"BAFFI ROBERT","owner_display_name":"BAFFI ROBERT","owner_url":"/insider/0001274826","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":31.65,"price_display":"31.65","price_state":"stated","total_value":3165.0,"total_display":"3,165.00","total_whole":"3,165","shares_owned_after":54534.0,"shares_owned_after_display":"54,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-30","filed_date":"2008-07-31","scope":"insider"}],"collapsed":true,"next_cursor":"2008-07-30|4009714","ledger_fault":false,"count":{"value":479,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":469,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":479},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (EVP, Technical Operations)","n_filings":49,"first_seen":"2004-05-11","last_seen":"2018-08-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001274826","retrieved_at":"2026-08-26T06:16:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}